Fundraising FoxSenisca
2 known investors
Find your way into Senisca
38 people in our graph share verified history with the Senisca team — schools, employers, funds. One of them is your warm intro.
Anastasiya Giarlettaunlockedknows Lorna Harries · together at Senisca (overlapped)
×11knows the team · via UCL
SENISCA is a University of Exeter biotech developing RNA-based senotherapeutics that target dysregulated RNA splicing to reverse cellular senescence and treat age-related disease. Its work centers on modulating RNA biology to address the molecular mechanisms driving cellular ageing.
Founders & leadership
LH
Lorna HarriesFounder and CSOLorna Harries holds a personal chair in Molecular Genetics at the University of Exeter Medical School and leads research on RNA splicing dysregulation in aging. She founded SENISCA to translate discoveries linking alternative splicing to cellular senescence into RNA-based therapeutics for age-related diseases.
Investors · 2
APEX Ventureslisted by APEX VenturesVienna · $540K – $1.1M
How we know: funding news · Not right? Tell us
R42 GroupreportedSan Francisco
How we know: funding news · Not right? Tell us
Companies House · registry record
View on Companies House ↗- Registered name
- SENISCA LTD
- Company number
- 12948837
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 13 Oct 2020
- Registered office
- Innovation Centre University Of Exeter, Rennes Drive, Exeter, Devon, EX4 4RN
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 31 Dec 2025 · next due 30 Sept 2027
- Confirmation statement
- last made up to 12 Oct 2025 · next due 26 Oct 2026
Current officers · 7
- Edward Scott Beattie — director, appointed 1 Jul 2024
- Sarah Louise Cole — director, appointed 1 Jan 2024
- Timothy Peter Warren Edwards — director, appointed 1 Aug 2024
- Lorna Harries — director, appointed 13 Oct 2020
- Richard Ian Haycock — director, appointed 1 Jan 2024
- Benjamin Lee — director, appointed 13 Oct 2020
- Allan Benjamin Elias Weiner — director, appointed 1 Jan 2024
Source: Companies House public register · retrieved 27 Sept 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does Senisca do?
- SENISCA is a University of Exeter biotech developing RNA-based senotherapeutics that target dysregulated RNA splicing to reverse cellular senescence and treat age-related disease. Its work centers on modulating RNA biology to address the molecular mechanisms driving cellular ageing.
- Who founded Senisca?
- Senisca was founded by Lorna Harries.
- Who are Senisca's investors?
- Senisca's investors include APEX Ventures, R42 Group.